This is a routine governance filing with no material financial implications. No immediate action required; monitor for any upcoming shareholder meeting details.
OLMA drugs
OLMA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 30 $14.41entry
- T+1 · 7mo ago −0.62%α −0.84% · $14.32
- T+5 · 6mo ago +5.00%α +3.27% · $15.13
- T+20 · 6mo ago −8.47%α −13.69% · $13.19
- T+60 · 4mo ago −16.66%α −19.76% · $12.01
Price Chart
How similar events traded
Executive Summary
Olema Pharmaceuticals filed DEFA14A additional definitive proxy solicitation materials. The only substantive recent event is the appointment of Dr. Prakash Raman as an independent Class II director, which is a routine governance change with no material financial impact.
Key Facts
- Filed additional definitive proxy materials (DEFA14A)
- Board appointed Dr. Prakash Raman as independent Class II director on April 27, 2026
- Director granted standard stock options: 24,150 shares (3-year vest) and 2,911 shares (vests June 2026)
Financial Impact
No material financial impact; routine director compensation with standard option grants.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-191960 |
| Document: 0001193125-26-191960-index-headers.html | 0001193125-26-191960 |
| Document: 0001193125-26-191960-index.html | 0001193125-26-191960 |
| Document: 0001193125-26-191960.txt | 0001193125-26-191960 |
Track record
20 reports on OLMA
1 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +38.44% at T+60 after the Aug 9, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.29 Now $7.36 +0.96% settles Feb 12
- Nov 12, 20264d ago 8-K Neutral 2/10 Entry $7.56 Now $7.36 −2.65% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $7.27 Now $7.36 +1.24% settles Feb 8
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $7.33 Now $7.36 +0.41% settles Feb 4
- Oct 16, 20264w ago SC 13D/A Neutral 2/10 Entry $7.11 Now $7.36 +3.52% settles Jan 14
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $6.58 Now $7.36 +11.85% settles Jan 13
- Oct 2, 20266w ago Press Release Neutral 2/10 Entry $8.25 Now $7.36 −10.79% settles Dec 30
- Aug 10, 202614w ago 8-K Neutral 5/10 No price data
- Aug 10, 202614w ago Press Release Neutral 4/10 Entry $10.43 to $7.54 Now $7.36 −29.43% ▼ −27.71% −27.22% vs SPY
- Aug 9, 202614w ago Institutional Cluster Bearish 6/10 Entry $11.94 to $7.35 Now $7.36 +38.36% ▲ +38.44% +36.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers